AstraZeneca vaccine could boost US supply next month, but heighten skepticism

Surprisingly strong US clinical trial results reported by AstraZeneca on Monday raised the prospect of a fourth COVID-19 vaccine in the United States soon — and a potential supply surplus just as the general public becomes eligible for shots in Massachusetts ...

from Google Alert - Business https://ift.tt/3tYROCL
Surprisingly strong US clinical trial results reported by AstraZeneca on Monday raised the prospect of a fourth COVID-19 vaccine in the United States soon — and a potential supply surplus just as the general public becomes eligible for shots in Massachusetts ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize